-

2024 CUDA丨Dr. Liqun Zhou: Spotlight on Innovation, Domestic Surgical Robots at the Global Forefront
From August 8th to 11th, 2024, the Annual Meeting of the Urology Physicians Branch of the Chinese Medical Doctor Association (CUDA) was held in Xi’an. The conference, organized by the Chinese Medical Doctor Association and the Urology Physicians Branch, and hosted by Xijing Hospital of the Air Force Medical University, with support from the Urology…
-

2024 CUDA | Dr. Jianming Guo: Addressing Clinical Needs of Prostate Cancer in China – Exploring Treatment Prospects from Diagnosis to Surgery
From August 8-11, 2024, the Annual Meeting of the Chinese Urological Association (CUDA) was held in Xi’an, hosted by the Chinese Medical Doctor Association and its Urological Physician Branch, organized by Xijing Hospital of the Air Force Medical University, and co-hosted by the Urology Physician Branch of the Shaanxi Medical Doctor Association. Under the theme…
-

International Lung Cancer Conference | Dr. Wentao Fang: Neoadjuvant Therapy for Locally Advanced NSCLC
Treating locally advanced lung cancer is a significant clinical challenge, with perioperative treatment being key to improving patient outcomes. At the 2024 International Lung Cancer Conference (CLC 2024), Dr. Wentao Fang from Shanghai Chest Hospital delivered a presentation titled “Neoadjuvant Therapy for Locally Advanced NSCLC.” This article provides a brief overview of his report.
-

2024 CUDA | Dr. Tao Xu: Addressing the Challenges of Prostate Cancer Androgen Deprivation Therapy, Optimal Treatment Strategies, and Future Directions
Androgen deprivation therapy (ADT), also known as castration therapy, involves lowering male hormone levels through surgery or medication to treat prostate cancer. Recently, the 2024 Annual Meeting of the Chinese Urological Association (CUDA) was successfully held in Xi’an. Following the event, Urology Frontier invited Dr. Tao Xu, Director of Urology at Peking University People’s Hospital,…
-

Dr. Yew Kuo Chao: The future treatment direction of MAFLD will be more personalized
Recently, the Combined GlHep&SHC 2024 was successfully held in Singapore. This conference covers various aspects of liver disease research and provides an interdisciplinary communication platform for experts and scholars. During the conference, Hepatology Digest invited Dr. Yew Kuo Chao, a senior consultant at Tan Tock Seng Hospital, Singapore, to discuss topics related to metabolic associated…
-

2024 CUDA丨Dr. Weijun Qin: Unprecedented CUDA Conference Advances Urology, Innovations in Xenotransplantation Enhance Patient Benefits
From August 8th to 11th, 2024, the Annual Meeting of the Urology Physicians Branch of the Chinese Medical Doctor Association (CUDA) was held in Xi’an. The conference was hosted by the Chinese Medical Doctor Association and the Urology Physicians Branch, organized by Xijing Hospital of the Air Force Medical University, and co-organized by the Urology…
-

2024 CUDA丨Dr. Sujun Han: Prostate Cancer Quality Control Indicators Aid in Standardizing Diagnosis and Treatment, Enhancing Both Survival and Quality
Prostate cancer is the most common malignancy of the male genitourinary system. Compared to Western countries, a larger proportion of prostate cancer patients in China are diagnosed at intermediate to advanced stages, leading to poorer prognosis. At the recent 2024 Annual Meeting of the Urology Physicians Branch of the Chinese Medical Doctor Association (CUDA), Urology…
-

2024 CUDA丨Dr. Nianzeng Xing: Special Sessions Propel New Productivity in Urology, Highlighting the Spirit of International Collaboration in Healthcare
In the journey toward a “Healthy China,” urology leads the way. From August 9th to 11th, 2024, the eagerly anticipated 2024 Annual Meeting of the Urology Physicians Branch of the Chinese Medical Doctor Association was grandly held in Xi’an. With a broad global perspective, the conference showcased the latest achievements in the field of urology…